{"id":63841,"date":"2025-09-29T19:31:14","date_gmt":"2025-09-29T17:31:14","guid":{"rendered":"https:\/\/ticker-noticiasep.microcontenidos.com\/NoticiaRSS.vbhtml?user=FRND562DLP&amp;cod=20250929193114"},"modified":"2025-09-29T19:31:14","modified_gmt":"2025-09-29T17:31:14","slug":"mundo-famar-group-dr-riku-rautsola-appointed-new-ceo","status":"publish","type":"post","link":"https:\/\/webciudadana.net\/?p=63841","title":{"rendered":"Mundo: FAMAR Group: Dr. Riku Rautsola Appointed New CEO"},"content":{"rendered":"\n<p>(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n<p>\nATHENS, Greece, Sept. 29, 2025 \/PRNewswire\/ &#8212; After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025.<\/p>\n<p> Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through multiple ownership transitions, improving operations and customer service and setting a vision for future growth.<\/p>\n<p> At the same time, FAMAR Group is pleased to announce the appointment of Dr. Riku Rautsola as CEO, effective September 29, 2025. Riku has served as a non-executive member of FAMAR&#8217;s Board of Directors and an advisor to MidEuropa during the acquisition of FAMAR last year. Riku is a globally experienced leader in the pharmaceutical, biotech and CDMO industries, having held CEO and senior executive positions at several leading companies, creating sustained profitable growth<\/p>\n<p>\nUnder Riku&#8217;s leadership, FAMAR remains committed to serve its global customers, expand production capacity, accelerate its development partnerships, and invest in its people. Riku will also continue to serve as a member of the Board of Directors.<\/p>\n<p> Kostas will support Riku and the Board of Directors in a senior advisory capacity, focusing on strategic customer relationships and customer engagement.<\/p>\n<p> \u00abWe thank Kostas Rengis for his many years of dedicated service, and we extend a warm welcome to Riku Rautsola as he leads FAMAR in this next chapter of growth and transformation\u00bb, stated Matthew Strassberg, Partner and Head of Healthcare at MidEuropa.<\/p>\n<p> About Famar Group<\/p>\n<p>\nFAMAR is a leading European provider of pharmaceutical and cosmetic manufacturing and development services. With a legacy of 75 years, FAMAR delivers high-quality dosage forms, including sterile liquids, solids, and semi-solids, creating value for its clients. Operating in Spain, Italy, and Greece, employing over 1.850 people across a network of six production facilities and two R&amp;D centres, FAMAR supplies a wide range of more than 1.700 different products for over 80 international markets.<\/p>\n<p> View original content:https:\/\/www.prnewswire.co.uk\/news-releases\/famar-group-dr-riku-rautsola-appointed-new-ceo-302569813.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Informaci\u00f3n remitida por la empresa firmante) ATHENS, Greece, Sept. 29, 2025 \/PRNewswire\/ &#8212; After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-63841","post","type-post","status-publish","format-standard","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63841"}],"version-history":[{"count":0,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63841\/revisions"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}